Thompson Siegel & Walmsley LLC Pfizer Inc Transaction History

Thompson Siegel & Walmsley LLC

$6.24 Billion
Q2 2024

A detailed history of Thompson Siegel & Walmsley LLC transactions in Pfizer Inc stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 479,885 shares of PFE stock, worth $13.2 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

479,885

Previous 453,606 5.79%

Holding current value

$13.2 Million

Previous $12.6 Million 6.67%

% of portfolio

0.22%

Previous 0.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$25.26 - $29.6 $663,807 - $777,858	26,279 Added 5.79%	479,885 $13.4 Million
Q1 2024 May 09, 2024	SELL	$25.89 - $29.73 $1.5 Million - $1.72 Million	-57,938 Reduced 11.33%	453,606 $12.6 Million
Q4 2023 Feb 07, 2024	BUY	$26.13 - $33.94 $85,262 - $110,746	3,263 Added 0.64%	511,544 $14.7 Million
Q3 2023 Nov 08, 2023	BUY	$32.09 - $37.51 $1.01 Million - $1.18 Million	31,445 Added 6.59%	508,281 $16.9 Million
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $173,556 - $200,800	-4,805 Reduced 1.0%	476,836 $17.5 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $276,045 - $359,370	7,008 Added 1.48%	481,641 $19.7 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $19.8 Million - $25.9 Million	474,633 New	474,633 $24.3 Million
Q3 2022 Oct 25, 2022	BUY	$43.76 - $53.42 $1.04 Million - $1.27 Million	23,833 Added 5.24%	478,409 $20.9 Million
Q2 2022 Jul 22, 2022	BUY	$46.53 - $55.17 $3.67 Million - $4.36 Million	78,967 Added 21.02%	454,576 $23.8 Million
Q1 2022 Apr 26, 2022	BUY	$45.75 - $56.69 $3.39 Million - $4.2 Million	74,081 Added 24.57%	375,609 $19.4 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $33,345 - $49,428	-807 Reduced 0.27%	301,528 $17.8 Million
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $1.36 Million - $1.74 Million	34,537 Added 12.9%	302,335 $13 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $3.43 Million - $3.89 Million	95,531 Added 55.46%	267,798 $10.5 Million
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $535,069 - $603,451	-15,977 Reduced 8.49%	172,267 $6.24 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $91,774 - $116,699	-2,742 Reduced 1.44%	188,244 $6.93 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $361,600 - $424,240	-11,389 Reduced 5.63%	190,986 $7.01 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $107,106 - $129,936	3,556 Added 1.79%	202,375 $6.62 Million
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $649,828 - $928,463	-24,041 Reduced 10.79%	198,819 $6.49 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $228,958 - $259,838	-6,955 Reduced 3.03%	222,860 $8.73 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $63,258 - $82,027	-1,947 Reduced 0.84%	229,815 $8.26 Million
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $981,782 - $1.1 Million	-26,549 Reduced 10.28%	231,762 $10 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $210,937 - $231,750	-5,625 Reduced 2.13%	258,311 $11 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $2.08 Million - $2.37 Million	-54,023 Reduced 16.99%	263,936 $11.5 Million
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $1.7 Million - $2.06 Million	-49,202 Reduced 13.4%	317,959 $14 Million
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $397,804 - $424,099	-12,062 Reduced 3.18%	367,161 $13.3 Million
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $287,509 - $333,550	-9,010 Reduced 2.32%	379,223 $13.5 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $245,758 - $260,757	-7,389 Reduced 1.87%	388,233 $14.1 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $7,006 - $7,717	226 Added 0.06%	395,622 $14.1 Million
Q2 2017 Aug 09, 2017	BUY	N/A	395,396	395,396 $13.3 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Account

Thompson Siegel & Walmsley LLC Pfizer Inc Transaction History